scholarly article | Q13442814 |
P50 | author | Salim Yusuf | Q2214381 |
Hans-Christoph Diener | Q25935337 | ||
David J. Gladstone | Q41564864 | ||
John W. Eikelboom | Q42846212 | ||
Alvaro Avezum | Q48865428 | ||
P2093 | author name string | Eric E Smith | |
Jun Zhu | |||
Robert G Hart | |||
Stuart Connolly | |||
Mukul Sharma | |||
Greg Flaker | |||
Martin J O'Donnell | |||
Rafael Dias | |||
Gayle Lewis | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | apixaban | Q414462 |
brain infarction | Q18555944 | ||
P304 | page(s) | 145-150 | |
P577 | publication date | 2016-04-17 | |
P1433 | published in | American Heart Journal | Q2227156 |
P1476 | title | Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study | |
P478 | volume | 178 |
Q47407548 | Anticoagulant use in atrial fibrillation and risk of dementia: review of contemporary knowledge |
Q92955488 | Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline |
Q57789140 | Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage |
Q40134938 | Cerebral amyloid angiopathy and implications for atrial fibrillation management |
Q64104985 | Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review |
Q57060141 | Cognitive dysfunction in atrial fibrillation |
Q98946700 | Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy |
Q90564373 | Management of Cerebral Microbleeds in Clinical Practice |
Q88601355 | Management of Embolic Stroke of Undetermined Source (ESUS) |
Q47102311 | Recent advances in the management of transient ischemic attacks |
Q57157880 | The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation |
Q38636940 | The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. |
Q92977571 | Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways |
Search more.